# Presentation: 244222

## Partnership between 

**Partnership between **
**the Global Fund and PEPFAR**

**Vinand M Nantulya, MD, PhD**
**Presentation to PACHA **
**March 29, 2004**

## Presentation plan

**PEPFAR and the Global Fund in 14 focus countries**
**PEPFAR and the Global Fund in other countries**
**Policy and resource challenges to the partnership**

## 1.    Partnership in focus countries

**Extensive complementarities in focus**
**countries. PEPFAR and the Global Fund**
**are funding activities to:**
**Scale up prevention, care, and support**
**Scale up anti-retroviral treatment**
**Provide support and care to orphans and other vulnerable children  **
**Invest in strengthening countries’ health systems**

## Example

**PEPFAR is to provide Kenya with ARVs worth USD 40 million to scale up treatment at 30 centers, amongst other interventions.**
**The 30 centers have been established, and with staff trained, using resources from the Government of Kenya and the Global Fund.**
**There is consultation and coordination at country level **
** **

## 2. Partnership in other countries

**Over 121 countries are supported **
**indirectly by PEPFAR through the **
**Global Fund. The approved proposals**
**Are consistent with PEPFAR’s mission, **
**as shown in the slides that follow**

## Most proposals to the Global Fund are targeting prevention 

**Voluntary Counseling and Testing**

**Condom promotion & distribution**

**Blood Safety**

**Mother-to-Child Transmission**

**Safe medical Practices**

**Post-Exposure Prophylaxis**

**Most proposals to the Global Fund are targeting prevention **

**% proposals**

**Behavior change communication**

**100**

## Population groups targeted by prevention include

**School Children**

**Workers in work  place**

**Youth out of School**

**MSM**

**Women**

**Prisoners**

**Military personnel**

**Mobile Populations**

**Population groups targeted by prevention include**

**Percent **

##  Most Proposals Integrate treatment with care and Support

**Provide HAART Medications**

**Strengthen HAART Programs**

**Home-Based/Palliative Care**

**Provide Opportunistic Infection Medications**

**Percent **

-  **Most Proposals Integrate treatment with care and Support**

## The Global Fund has approved 225 Grants worth USD 2 billion from 121 countries

- Ghana

- Mali

- China

- Mongolia

**Round 1**

**Round 2**

**Algeria**
**Morocco**
**Senegal**
**Mauritania**
**Mali**
**Guinea**
**Guinea Bissau**
**The Gambia**
**Sierra Leone**
**Burkina Faso**
**Togo**
**Côte d’Ivoire**
**Liberia**
**Niger**
**Cameroon**
**Gabon**
**Rwanda**

**Iran**
**Yemen**
**Eritrea**
**Ethiopia**
**Somalia**
**Sudan**
**Kenya**
**Comoros**
**Mozambique**
**Uganda**
**Chad**
**Burundi**
**Swaziland**
**Madagascar**
**Tanzania**
**Malawi**
**Lesotho**
**Zimbabwe**

**Haiti**
**Cuba**
**Dominican Republic**
**Jamaica**
**Guatemala**
**Belize**
**El Salvador**
**Nicaragua**
**Costa Rica**
**Honduras**
**Guyana**
**Panama**
**Colombia**
**Ecuador**
**Peru**
**Bolivia**
**Paraguay**
**Chile**
**Argentina**
**Multi-country Americas***

**Kazakhstan**
**Mongolia**
**Kyrgyzstan**
**North Korea**
**China**
**Afghanistan**
**Pakistan**
**Nepal**
**Laos**
**Myanmar**
**Philippines**
**Indonesia**
**East Timor**
**Vietnam**
**Cambodia**
**Thailand**
**Bangladesh**
**India**
**Sri Lanka**
**Papua New Guinea**
**Western Pacific Islands****

**Angola**
**Zambia**
**DR Congo**
**Central African Republic**
**Ghana**
**Namibia**
**Benin**
**Nigeria**
**Botswana**
**South Africa**

**Russian Federation**
**Ukraine**
**Moldova**
**Armenia**
**Egypt**
**Jordan**
**Tajikistan**
**Uzbekistan**
**Belarus**

**Round 3**

**Estonia**
**Bulgaria**
**Romania**
**Georgia**
**Serbia**
**Croatia**
**Macedonia**

## Distribution of Approved Grants for Rounds 1-3 by Region

**Africa**

**S/E Asia**

**Americas**

**Europe**

**W/**
**Pacific**

**E/**
**Med**

## Agreements signed & disbursements made 

**Grant Agreements**

**Disbursements**

## Half of funds are going to the public sector and half to non-public sector entities* 

- Half of funds are going to the public sector and half to non-public sector entities*

**Private sector (5%)**

**People living with **
**HIV/TB/malaria (3%)**

**Government **
**(50%)**

**Other (6%)**

**NGOs (29%)**

**Academic &**
**Educational organizations (3%)**

- * Rounds 2 and 3

- TRP outcome-2002-12-18-For Board report

## 3.Critical challenges

**      ****(i) Need for continuity of Global Fund’s Board approved policies on drug procurements implemented in many countries since October 2002. Based on 4 essential criteria:**
**Lowest price**
**Assured quality**
**Competitive tendering**
**Conformity with national and international law**

## Critical challenges (cont’d) 

**     ****(ii)  Further US contributions to the fight  against HIV/AIDS in the 100+ other countries through contributions to the Global Fund**
**USD ****547 Million**** for Y04 (1/3 Need of USD 1.7 billion for Y04)**
**USD ****1.2 billion**** for Y05 (1/3 Need of USD 3.6 billion for Y05)**

## Critical challenges (cont’d) 

**     ****(iii)  Letting countries and communities take charge of their own destiny, so they can prioritize and implement what works best in their social contexts.**

## Critical challenges (cont’d) 

**     ****(iv)  Building a culture of research evidence based policy and practice.**

## I thank You